Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Stanley Druckenmiller, Ray Dalio, Glenview Capital Management, Paulson & Co., Universal Health Services, Inc. (UHS), Ormat Technologies, Inc. (ORA), and More

Druckenmiller Alumni at PointState Are Looking for New Investors (Bloomberg)
PointState Capital, the macro hedge fund started by former traders for billionaire Stan Druckenmiller, is looking for new investors as it struggles to rebound from last year’s double-digit loss. The $6 billion firm’s main SteelMill Fund dropped about 19% in 2018 and has barely made money this year, climbing less than 1% through September, according to people familiar with the firm. PointState has rarely opened to new money since it began trading in 2011.

Paulson Gives Up Opposition to Reduced Callon-Carrizo Deal (Reuters)
(Reuters) – Callon Petroleum Co shareholder Paulson & Co. said on Monday it would now not oppose the U.S. shale producer’s purchase of smaller rival Carrizo Oil & Gas Inc, after the company last week sharply cut its offer. Billionaire investor John Paulson’s hedge fund, which had earlier said the deal was too expensive, also reduced its stake in Callon but did not give any details on its latest holding. Paulson held 9.5% in the company as of Nov. 6.

Billionaire Ray Dalio Says Retail Investors should Not Make this Big Mistake (CNBC)
Billionaire hedge fund manager Ray Dalio wants the average investor to learn from the errors of others. In fact, the “biggest mistake” he sees investors make is thinking that markets that went up recently are “better bargains rather than expensive bargains.” “Don’t make the mistake of buying those things that have gone up thinking they’re better rather than more expensive,” Dalio recently told CNBC’s Leslie Picker at the Greenwich Economic Forum in Connecticut.



DNB to Bolster Absolute Return Offerin (Hedge Nordic)
Stockholm (HedgeNordic) – DNB Asset Management announced plans to expand its range of absolute returns strategies with the upcoming launch of DNB Fund Multi Asset. The soon-to-be-launched fund will invest across several markets such as equities, currencies, rates and credit by blending both discretionary and systematic strategies. “With a strong belief in the merits of absolute return strategies, DNB are excited to be extending our absolute return offering through the upcoming launch of DNB Fund Multi Asset,” writes Lena Öberg, who focuses on manager selection within Absolute Return Investments at DNB.

Glenview’s Bullish Call on Health Care Is Playing Out So Far (Bloomberg)
Earlier this year, Glenview Capital Management founder Larry Robbins told investors they were wrong to fear Medicare for All proposals as he boosted his stake in health-care holdings, which were under pressure from political headlines. So far, his call is playing out well.

Hedge Fund Activism Can have Positive Longer-term Effects on Companies, Says New Research (Hedge Week)
Activist hedge fund investors can deliver positive results for companies, according to new research from Columbia Business School’s Professor Wei Jiang, Arthur F Burns Professor of Free and Competitive Enterprise. Examining the effects of hedge fund interventions specifically on corporate innovation, Jiang reveals that third-party interventions can actually increase the longevity and sustainability of a company’s innovation – particularly with inventors and inventions. Hedge fund activism leads to companies using R&D dollars more efficiently, contradicting commonly held beliefs that hedge fund activism focuses companies on unsustainable short-term goals.

Activist Investor Takes Another Bite at Medifast (The Wall Street Journal)
An activist investor is coming back for a second serving of nutrition and weight-loss company Medifast Inc. Activist investor Engaged Capital LLC has taken a large position in the company-its second time targeting Medifast-with plans to push for change, including operational fixes, board structure and alternatives that can close the gap between what Engaged believes Medifast’s stock should be worth and where it is currently trading.

Carl Icahn Will Not Be Presiding Over The Shotgun Wedding Of Xerox And HP Just Yet (Deal Breaker)
Have you heard the blessed news? There is peace in our time, between the activist hedge funds and their targets. Appeasement works, even on Paul Singer. A new playbook is emerging in the world of shareholder activism, one that calls for quick peace treaties enabling investors and the companies they target to sidestep costly, protracted battles… The new setups are more like nonbinding handshake agreements… Elliott Management Corp..., one of the most prolific and aggressive activists, plans to use them as a template in future campaigns, according to a person familiar with the matter. This is because activist campaigns are expensive and bruising and, oh yea, decreasingly remunerative.

Hedge Fund Starts a Quant Trading Desk in Brazil Comeback Bid (Bloomberg)
Marcelo Giufrida is drawing inspiration from Jim Simons’ Renaissance Technologies LLC as he works to lure investors back to his Brazilian firm’s flagship hedge fund. Giufrida’s Garde Asset Management Ltda. put together a five-person team to start a quantitative-trading desk, partially inspired by Renaissance and other global hedge funds that have been successful with the approach, he said in an interview. The launch is part of a comeback bid for the fund, the Garde D’Artagnan Master, which lost half its assets in little over a year.

Investing in Founder-Led Companies (Hedge Nordic)
Stockholm (HedgeNordic) – Andreas Aaen operates under the motto of “putting your money where your mouth is,” which has proven successful thus far. After all, Symmetry Invest generated an annualized return of 17.3 percent since launching in March of 2013 despite suffering a bad year in 2018. Mistakes had been made and learned from, says Aaen, and the fund has recouped last year’s losses after gaining nearly 28 percent year-to-date. After successfully managing his own money and capital from friends and family for a few years, Andreas Aaen decided to open up his long/short value equity fund to outside investors.

Here Are The Billionaires Funding The Democratic Presidential Candidates (Forbes)
Billionaires are everywhere in the 2020 election. Donald Trump, of course, is the incumbent. Howard Schultz, of Starbucks fame, considered launching a campaign to challenge him. Then Tom Steyer, the hedge fund billionaire, actually did. Now Michael Bloomberg, who is richer than all of them, is reportedly positioning to do the same. And while those four made the headlines, around 100 other billionaires have been quietly donating to Democratic hopefuls.

Lions Gate: This Famous Investor Just Bought In (Seeking Alpha)
Gordon Crawford (Gordy), considered as a heavyweight media investor and presently on the board of Lions Gate Entertainment Corp. (NYSE:LGF.A) (NYSE:LGF.B), picked up 122,414 shares at an average price of $8.87 between 11 and 14 Nov 19.

Notable Insider Buys In The Past Week: Arvinas, Dropbox, Trinity (Benzinga)
Arvinas: An Arvinas Inc (ARVN) director stepped up to the buy window this past week. That director took advantage of a secondary stock offering to indirectly pick up 680,000 shares of this biopharmaceutical company at $22.00 apiece. That transaction totaled about $14.96 million. Note that the company’s chief science officer sold 10,000 shares last week as well. The stock closed Friday at $30.49 a share, after hitting a 52-week high of $30.85 last week. The shares popped about 18% in the past week and are more than 120% higher year to date. Analysts currently anticipate the share price will go to $33.50.

Universal Health Services Inc (UHS) Executive Vice President & CFO Steve Filton Sold $4.2 million of Shares (Guru Focus)
Executive Vice President & CFO of Universal Health Services Inc., Steve Filton, sold 30,000 shares of UHS on 11/15/2019 at an average price of $141.4 a share. The total sale was $4.2 million. Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Universal Health Services Inc has a market cap of $12.64 billion; its shares were traded at around $144.30 with a P/E ratio of 17.97 and P/S ratio of 1.16.

The E.V.P. Electricty Segment of Ormat Technologies (NYSE: ORA) is Selling Shares (Analyst Ratings)
Today, the E.V.P. Electricty Segment of Ormat Technologies (ORA), Zvi Krieger, sold shares of ORA for $51.36K. Following Zvi Krieger’s last ORA Sell transaction on August 12, 2019, the stock climbed by 5.7%. Based on Ormat Technologies’ latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $170 million and quarterly net profit of $15.61 million.

SEC Awards Over $260,000 to Whistleblowers for Their Help in Spotting Securities Fraud (
(HedgeCo.Net) The Securities and Exchange Commission has announced an award to three individuals who jointly submitted a tip alerting the agency to a well-concealed fraud targeting retail investors. The information led to a successful enforcement action. The whistleblowers, who were themselves harmed investors, will collectively receive a payment of over $260,000 based on current collections. “Because of the whistleblowers’ information and assistance early in the investigation, the SEC had strong evidence about a fraudulent scheme operated by recidivist violators,” said Jane Norberg, Chief of the SEC’s Office of the Whistleblower. “This matter exemplifies the importance of the SEC’s whistleblower program to the agency’s enforcement efforts and commitment to protect investors.”

Delek Us Holdings Inc (DK) Chairman / President / CEO Ezra Uzi Yemin Bought $985,875 of Shares (Guru Focus)
Chairman / President / CEO of Delek Us Holdings Inc., Ezra Uzi Yemin, bought 27,500 shares of DK on 11/15/2019 at an average price of $35.85 a share. The total cost of this purchase was $985,875. Delek US Holdings Inc is an oil and gas company that is engaged in petroleum refining, transportation, storage and wholesale of crude oil and intermediate and refined products and convenience store retailing.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.